Literature DB >> 12904329

Overexpression of PKC-betaI and -delta contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats.

Mohammad Asghar1, Tahir Hussain, Mustafa F Lokhandwala.   

Abstract

Previously, we reported that natriuretic and diuretic response to dopamine is diminished in old Fischer 344 rats, which is due to higher basal protein kinase C (PKC) activity and hyperphosphorylation of Na-K-ATPase in the proximal tubules (PTs) of old rats. The present study was conducted to determine whether higher PKC activity could be due to altered expression of some of the PKC isoforms in the superficial cortex (rich in PTs) of old rats. Fluorimetric measurement showed almost twofold increase in the PKC activities in homogenates and membranes of old (24 mo) compared with adult (6 mo) rats. Interestingly, in the basal state PKC-betaI was overexpressed in the membranes, whereas PKC-delta expression was increased in the cytosol of old compared with adult rats. Treatment of the cortical slices with either SKF-38393, a D1-like agonist, or PDBu, a direct activator of PKC, caused translocation of PKC-betaI from cytosol to membranes in adult but not in old rats. Both of these drugs caused translocation of PKC-delta from membranes to cytosol in adult but not in old rats. These drugs had no effect on translocation of PKC-zeta in both adult and old rats. Both PKC-betaI and -delta co-immunoprecipitated with alpha1-subunit of Na-K-ATPase in adult and old rats. These observations suggest that both SKF-38393 and PDBu differentially regulate PKC-betaI and -delta in adult but not in old rats. Also, PKC-betaI and -delta seem to interact with Na-K-ATPase in these animals. The overexpression of both PKC-betaI and -delta in old rats could be responsible for a higher basal PKC activity, which causes the hyperphosphorylation of Na-K-ATPase and contributes to the diminished inhibition of Na-K-ATPase activity by dopamine in old rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904329     DOI: 10.1152/ajprenal.00198.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  7 in total

1.  Novel role of RGS2 in regulation of antioxidant homeostasis in neuronal cells.

Authors:  Samina Salim; Mohammad Asghar; Manish Taneja; Iiris Hovatta; Yuh-Lin Wu; Kaustuv Saha; Nada Sarraj; Brian Hite
Journal:  FEBS Lett       Date:  2011-04-16       Impact factor: 4.124

2.  Regulation and identification of Na,K-ATPase alpha1 subunit phosphorylation in rat parotid acinar cells.

Authors:  Stephen P Soltoff; John M Asara; Lee Hedden
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

3.  Overexpression of Na(+)/K (+)-ATPase parallels the increase in sodium transport and potassium recycling in an in vitro model of proximal tubule cellular ageing.

Authors:  E Silva; P Gomes; P Soares-da-Silva
Journal:  J Membr Biol       Date:  2007-02-28       Impact factor: 1.843

4.  Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.

Authors:  TanYa M Gwathmey; Karl D Pendergrass; Sean D Reid; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

Review 5.  Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice.

Authors:  Xiaoyan Wang; Van Anthony M Villar; Ines Armando; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Pediatr Nephrol       Date:  2008-07-10       Impact factor: 3.714

6.  Human kidney-2 cells harbor functional dopamine D1 receptors that require Giα for Gq/11α signaling.

Authors:  Indira D Pokkunuri; Gaurav Chugh; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

Review 7.  Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice.

Authors:  Chunyu Zeng; Ines Armando; Yingjin Luo; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-12-14       Impact factor: 4.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.